- Home
- NEOV vs TVGN Comparison
NEOV vs TVGN Comparison
Compare NEOV & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEOV
- TVGN
- Stock Information
- Founded
- NEOV 2018
- TVGN 2020
- Country
- NEOV United States
- TVGN United States
- Employees
- NEOV N/A
- TVGN N/A
- Industry
- NEOV Industrial Machinery/Components
- TVGN Blank Checks
- Sector
- NEOV Miscellaneous
- TVGN Finance
- Exchange
- NEOV Nasdaq
- TVGN Nasdaq
- Market Cap
- NEOV 181.8M
- TVGN 174.4M
- IPO Year
- NEOV N/A
- TVGN N/A
- Fundamental
- Price
- NEOV $4.17
- TVGN $1.28
- Analyst Decision
- NEOV Strong Buy
- TVGN
- Analyst Count
- NEOV 1
- TVGN 0
- Target Price
- NEOV $7.50
- TVGN N/A
- AVG Volume (30 Days)
- NEOV 303.3K
- TVGN 1.6M
- Earning Date
- NEOV 02-07-2025
- TVGN 02-20-2025
- Dividend Yield
- NEOV N/A
- TVGN N/A
- EPS Growth
- NEOV N/A
- TVGN N/A
- EPS
- NEOV N/A
- TVGN N/A
- Revenue
- NEOV $2,471,178.00
- TVGN N/A
- Revenue This Year
- NEOV $85.10
- TVGN N/A
- Revenue Next Year
- NEOV $281.25
- TVGN N/A
- P/E Ratio
- NEOV N/A
- TVGN N/A
- Revenue Growth
- NEOV N/A
- TVGN N/A
- 52 Week Low
- NEOV $0.63
- TVGN $0.26
- 52 Week High
- NEOV $6.11
- TVGN $21.09
- Technical
- Relative Strength Index (RSI)
- NEOV 41.27
- TVGN 52.84
- Support Level
- NEOV $3.98
- TVGN $1.20
- Resistance Level
- NEOV $4.91
- TVGN $1.57
- Average True Range (ATR)
- NEOV 0.48
- TVGN 0.15
- MACD
- NEOV -0.11
- TVGN 0.02
- Stochastic Oscillator
- NEOV 10.22
- TVGN 50.09
About NEOV NeoVolta Inc.
NeoVolta Inc is engaged in designing, manufacturing and sale of high end Energy Storage System which can store and use solar energy via batteries and an inverter at a residential site. Its market place includes solar industry, installers, new construction homebuilders, home remodelers and homeowners.
About TVGN Tevogen Bio Holdings Inc. Common Stock
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes ("CD8+ CTLs" or "CTLs"), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.